• MRI of tissue fibrosis without contrast agent (No. 1665)

    Scientist: Michal Neeman

    Improved magnetic resonance imaging (MRI) for cardiac fibrosis and other fibrotic diseases.Myocardial fibrosis is associated with worsening ventricular systolic function, abnormal cardiac remodeling, and increased ventricular stiffness, significantly increasing the risk of adverse cardiac outcomes. Hypertension and diabe ... Read more
  • Methods for high-throughput analysis of transcriptomes (No. 1843)

    Scientist: Ido Amit

    Analysis of the transcriptome of cells can inform greatly about the state of said cells, including maturation, activation, transformation, etc. Therefore it would be of great research and clinical value to analyze transcriptomes of different cell populations and to compare gene expression on large scales. A particularly ... Read more
  • MyRepair Blood test to identify people at high risk for lung cancer (No. 1033)

    Scientist: Zvi Livneh

    A novel diagnostic test to identify individuals with increased risk of lung cancer. Lung cancer is the number one killer among cancers, with 160,000 deaths/year in the USA and 1.6 million/year worldwide. Early detection of lung cancer increases 5-year survival rate from 4% to 54%. Moreover, the National Lung Cancer Trial ... Read more
  • Fully Naive Induced Human Pluripotent Stem Cells (iPSC) (No. 1671)

    Scientist: Jacob (Yaqub) Hanna

    A novel method to revert human iPSC to a fully naive state, retaining stable pluripotency. The feasibility for the existence of ground state naive pluripotency in human embryonic stem cells (hESC) has long been researched. This innovative technology supplies the composition of chemically defined conditions required for d ... Read more
  • A Novel Approach for Controlling Gene Expression (Arbirtium - a Novel approach) (No. 1847)

    Scientist: Rotem Sorek

    One of the challenges in the areas of synthetic biology and its clinical applications, is the capacity to control the induction of different genes, whether for the purpose of activating genetic circuits or inducing the expression of a specific protein. Present approaches are limited to the number of systems available, in ... Read more
  • Cholesterol Antibodies (No. 1267)

    Scientist: Lia Addadi

    Description: Monoclonal antibodies specific for cholesterol/ceramide-rich domains (clones 405F, 14F, 499F) and cholesterol micro-domains (clones 36A1, 5881) in cell membranes. Originally raised against an artificial monolayer of lipid mixtures in, and were shown to specifically label the above domains in different cell ... Read more
  • Mutant P53 reactivating peptides as a novel cancer therapy (No. 1672)

    Scientist: Varda Rotter

    Newly developed p53-reactivating peptides were shown to cause regression of very aggressive tumors in several cancer models. p53 is the most important  tumor suppressor gene. Mutant p53 forms can instigate a cascade of events that may lead to loss of control of cell growth and proliferation, and eventually to cancer. p5 ... Read more
  • Novel Treatment for Lung Diseases by Allogeneic Cell Transplantation (No. 1868)

    Scientist: Yair Reisner

    The treatment of respiratory conditions is currently one of the major challenges to health care systems all over the world. The problem is that most therapeutics currently available for treating pulmonary indications are non-curative, and simply improve symptoms. Presently the only cure for late stage pulmonary diseases ... Read more
  • Mouse IgE and Anti-Mouse IgE Monoclonal Antibodies (No. 1270)

    Scientist: Zelig Eshhar

    Monoclonal antibodies to IgE Description: Rat monoclonal anti-IgE antibodies that was generated by fusion of plasmacytoma (84.1C) or myeloma (EM953) cells with splenocytes of rat immunized with purified murine IgE mAb. The antibodies react with various IgE mAb of different specificities and not with immunoglobulins of o ... Read more
  • On-Chip Synthesis of Biomolecules (No. 1369)

    A simple, single-step biochip platform for synthesis of biomolecules. Biochip technology is used today in measuring passive probe-target interactions i.e. measurement of the abundance of specific biomolecules). This technology can now be extended to include complex and cascaded activities on the chip. The present immobil ... Read more


Subscribe to Pharmaceuticals